Manifest Investing

In Pursuit of Pharma/BioTech Opportunity

Date: Tuesday, June 02 · 8:30 PM - 9:45 PM EDT
Location: Online

Ardelyx (ARDX) has generated a 107% return for the Round Table portfolio.

Other companies like Regeneron Pharma (REGN), Gilead Sciences (GILD) and BioSpecifics Technologies (BSTC) have proved particularly rewarding and have significantly bolstered the Round Table results.

Other exploits over the years have included a very rewarding tour with Walgreen as we watched them kiss and make up with Express Scripts. Back in 2012, Hugh delivered a couple of educational sessions on profiting from the FDA pipeline that still rank as some of the most favored (by an order of magnitude) sessions stored on our YouTube channel.

Hugh’s back.

Join us for this entertaining and educational webcast.

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 13.7%-18.7%
Yellow	PAR is above the target range of MIPAR +10%, currently 18.7%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.